DAVE LARSON — Lobbyist Profile | Poliscope

DAVE LARSON

Filings

Clients

Firms

Years active

2024–2026

Associated filing income

$215,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
SOLUTIONS DIAGNOSTICS	7	2024–2025
ENERGY SUBSTANTIATION PARTNERS LLC	5	2026

Lobbying firms

Firm	Filings	Years
THE BENNETT CONSULTING GROUP	12	2024–2026

Original LDA source filings (12)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

ENERGY SUBSTANTIATION PARTNERS LLC via THE BENNETT CONSULTING GROUP

2026 · third_quarter · Q3

Firm income: $45,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

TRD

Trade (domestic/foreign)

Cryptocurrency legislation

Filing targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE

ENERGY SUBSTANTIATION PARTNERS LLC via THE BENNETT CONSULTING GROUP

2026 · second_quarter · Q2

Firm income: $45,000Client expense: —

Source: Senate LDA

Show 8 more original filings

ENERGY SUBSTANTIATION PARTNERS LLC via THE BENNETT CONSULTING GROUP

2026 · first_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

ENG

Energy/Nuclear

Clarity Act and Responsible Financial Innovation Act (RFIA)

SOLUTIONS DIAGNOSTICS via THE BENNETT CONSULTING GROUP

2025 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SOLUTIONS DIAGNOSTICS via THE BENNETT CONSULTING GROUP

2025 · second_quarter · Q2

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SOLUTIONS DIAGNOSTICS via THE BENNETT CONSULTING GROUP

2025 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SOLUTIONS DIAGNOSTICS via THE BENNETT CONSULTING GROUP

2024 · fourth_quarter · Q4

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Health Care FDA Issues, Medical Device Manufacturer

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SOLUTIONS DIAGNOSTICS via THE BENNETT CONSULTING GROUP

2024 · third_quarter · Q3

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Health Care FDA Issues, Medical Device Manufacturer

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SOLUTIONS DIAGNOSTICS via THE BENNETT CONSULTING GROUP

2024 · second_quarter · Q2

Firm income: $15,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Health Care FDA Issues, Medical Device Manufacturer

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

SOLUTIONS DIAGNOSTICS via THE BENNETT CONSULTING GROUP

2024 · second_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Health Care/FDA Issues